Early diagnosis of eye disease with better retinal imaging

Article

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Researchers at the Lawrence Livermore National Lab (LLNL), the Indiana University School of Optometry, Boston Micromachines and the University of California, Davis have built three AO-OCT instruments with the help of the National Eye Institute. These devices provide non-invasive, ultra-high resolution, three-dimensional volumetric retinal images for ophthalmologists and optometrists to view the cellular level structure in the human retina. This capability is expected to allow doctors to diagnose retinal diseases early and follow their progression as well as track the progress of genetic therapies that reverse the diseases.

Using the same principles that allow astronomers to view distant objects the device reportedly represents a revolutionary advancement over current instruments.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.